I recently posted how constitutive overexpression of NRF2 is not recommended because it puts one at higher risk of cancer. A new study has shown that overexpression is also not beneficial for treating intestinal diseases like IBD and colitis in the acute phase. The study actually showed an increase of inflammation in the acute phase when mice were engineered to express NRF2 continuously even in a basal state. (This was not the case with nutritional supplementation of sulforaphane like in broccoli and the author suspects that normal cell function compensates during exposure to it.) The increases in NRF2 overexpression did not cause an increase of inflammation in a laboratory model (deficient IL-10 model) of bowel diseases in the chronic state. I also reported that mast cells are activated in reaction to oxidative stress but there is not a parallel production of Il-10. (See Note, Frossi) I would suggest that this kind of mast cell activation contributes to the chronic form of intestinal diseases especially when NRF2 is at low levels and almost like an "autoimmune condition" because body processes make oxidative stress and under stress conditions make more. Also, in the chronic mice model, lack of il-10 resulted in higher glutathione levels in female mice and was associated with a more severe form of the chronic state. The author noted that the reason for this is not known, and more studies need to be done. I suggest that this is the reason for the higher incidence of some environmental illnesses like intestinal diseases occur in women. The author summarized the results by saying "that treatments may be more successful NRF2 therapies will be more successful for the maintenance of remission, but not for acute flares of the disease." Source: Gerstgrasser A, Melhem H, Leonardi I, Atrott K, Schäfer M, Werner S, Rogler G, Frey-Wagner I. Cell-specific Activation of the Nrf2 Antioxidant Pathway Increases Mucosal Inflammation in Acute but Not in Chronic Colitis. J Crohns Colitis. 2017 Apr 1;11(4):485-499. doi: 10.1093/ecco-jcc/jjw172. PMID: 27683801.
Note: "The mechanisms underlying-oxidative stress of inflammatory markers differ from those that are IgE (allergy) mediated. This suggests that different signals can be activated under different physiological and pathological conditions." (Frossi)
Oxidative stress stimulates IL-4 and IL-6 production in mast cells by an APE/Ref-1-dependent pathway
Barbara Frossi, Marco De Carli, Kenn Curt Daniel, Juan Rivera, Carlo Pucillo.
First published: 07 July 2003

Comments
Post a Comment